By Nicholas Zamiska and Jason Leow
The Wall Street Journal Asia
18 Apr 2007
FOR INVESTORS, the Chinese pharmaceuticals sector is as fraught with risk as it is full of promise. For now, the best investment prescription may be caution. A spate of Chinese drug companies have listed shares in Hong Kong and New York this year, and... read more...
posted by Bank Report @ 6:11 AM
0 Comments:
Post a Comment
<< Home